Lexun Wang

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Cross Sectional

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Research (Washington, D.C.)

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Lexun Wang, Jiaojiao Feng, Yanyue Deng, Qianqian Yang, Quxing Wei, Dewei Ye, Xianglu Rong, Jiao Guo
CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding. Research (Washington, D.C.) 2022 (2022)
Xiao-Qiang Huang, Huixia Zhan, Jin Yang, Liufen Peng, Shenghua Piao, Lexun Wang, Tian Lan, Xianglu Rong, Jiao Guo
Long-Term Effect of Zhenzhu Tiaozhi Capsule (FTZ) on Hyperlipidemia: 2-Year Results from a Retrospective Study Using Electronic Medical Records. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Lexun Wang, Lei Xiang, Shenghua Piao, Xiao Gong, Wanxing Zhou, Weixun Feng, Huilin Li, Leyu Li, Aisheng Wei, Qing Zhu, Xianglu Rong, Jiao Guo
The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Diabetes, metabolic syndrome and obesity : targets and therapy 14 (2021)